FDA orphan drug designation: treatment of autosomal dominant polycystic kidney disease
All entries for: J & D Pharmaceuticals LLC
September 5, 2025
J & D Pharmaceuticals LLC
Orphan Drug Designation
Disease Area: Rare Diseases
FDA orphan drug designation: treatment of autosomal dominant polycystic kidney disease
